Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
CNS Drugs|July 5, 2021
Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for PharmacotherapyEthan S Burstein
Journal of Receptor and Signal Transduction Research|April 6, 2006
Constitutive activity of muscarinic acetylcholine receptorsTracy A Spalding, Ethan S Burstein
The Journal of Pharmacology and Experimental Therapeutics|October 1, 2013
The protease activated receptor 2 (PAR2) polymorphic variant F240S constitutively activates PAR2 receptors and potentiates responses to small-molecule PAR2 agonistsJian-Nong Ma, Ethan S Burstein
Bioorganic & Medicinal Chemistry Letters|March 27, 2014
Bexarotene prodrugs: targeting through cleavage by NQO1 (DT-diaphorase)Anja Schäfer, Ethan S Burstein, Roger Olsson
Pharmacology|December 20, 2016
Dronedarone Modulates M1 and M3 Muscarinic Receptors with Subtype Selectivity, Functional Selectivity, and Probe DependenceGihan M Jayasuriya, Gwendolynne Elmslie, Ethan S Burstein, et al.
ACS Chemical Neuroscience|July 27, 2016
Estrogen Receptor Beta Selective Agonists as Agents to Treat Chemotherapeutic-Induced Neuropathic PainJian-Nong Ma, Krista McFarland, Roger Olsson, et al.
ACS Chemical Neuroscience|May 25, 2021
Pimavanserin Promotes Trophic Factor Release and Protects Cultured Primary Dopaminergic Neurons Exposed to MPP+ in a GDNF-Dependent MannerElodie Gras Lavigne, Dorothée Buttigieg, Rémy Steinschneider, et al.
Neurochemical Research|April 1, 2014
On the discovery and development of pimavanserin: a novel drug candidate for Parkinson's psychosisUli Hacksell, Ethan S Burstein, Krista McFarland, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 9, 2013
Identification of the antiarrhythmic drugs amiodarone and lorcainide as potent H3 histamine receptor inverse agonistsAndria L Del Tredici, Jian-Nong Ma, Fabrice Piu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Homologous mutations near the junction of the sixth transmembrane domain and the third extracellular loop lead to constitutive activity and enhanced agonist affinity at all muscarinic receptor subtypesDiane J Ford, Anthony Essex, Tracy A Spalding, et al.
Pageof 6